Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with RVMD: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
RVMD
Revolution Medicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
RVMD
Revolution Medicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
RVMD, dashed
Supply-chain overlap
Revenue flow
RVMD: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only RVMD
6
SNY
Sanofi
customer
RPRX
Royalty Pharma Investments 2019 ICAV (Royalty Pharma)
customer
—
Aethon Therapeutics
unlisted
supplier
—
Continental Stock Transfer & Trust
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
2 more · RVMD chain
›
AMGN
Amgen Inc
Change
467.00
▼
−2.40%
Mkt cap
$258.8B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
RVMD
Revolution Medicines, Inc.
Change
185.70
▼
−7.01%
Regular session
Nov 5 '26
Mkt cap
$43.2B
Revenue
$198M
Q3 FY26
Revenue
—
vs
Compare
Regular session
Nov 5 '26
AMGN
Amgen Inc
vs
RVMD
Revolution Medicines, Inc.
467.00
▼
−2.40%
Price
185.70
▼
−7.01%
$258.8B
Mkt cap
$43.2B
Q3 FY26
$10.4B
Revenue
$198M
Q3 FY26
FY25
$36.8B
Revenue
—
Change
Change
AMGN
467.00
▼
−2.40%
vs
RVMD
185.70
▼
−7.01%
Regular session
Nov 5 '26